Company / Revenue per Share
Corbus Pharmaceuticals Holdings, Inc. Revenue per Share History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.21
FY2022
5-year range
$0.04 / $0.56
FY2018-FY2022
Trend
+430.9%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share changed +431% YoY in FY2022, a notable deviation from the 7-year average annual change of +160%.
Based on SEC 10-K filings.
0.21 in FY2022 with a 5-year CAGR of +65.1%.
Declined from $0.56 to $0.21 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +35.9%
- 5-Year CAGR
- +65.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, revenue per share increased 430.9% year-over-year.
- Peak revenue per share was recorded in FY2020.
- Lowest revenue per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.21 | +430.9% |
| FY2021 | $0.04 | -92.9% |
| FY2020 | $0.56 | +563.5% |
| FY2019 | $0.08 | +91.9% |
| FY2018 | $0.04 | +154.5% |
| FY2017 | $0.02 | +0.0% |
| FY2016 | $0.02 | -31.0% |
| FY2015 | $0.02 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026